(b)(4).Manufacturing site evaluation: samples received: none, pictures received showing the defect.Analysis and results: there are no previous complaints of this code batch of which (b)(4) units were manufactured and distributed in the market.There are no units in stock in the warehouse.No samples have been received but pictures attached shows a secondary packaging with a primary packaging without product.Between the different orders empty packages are driven to exclude a mixing with the respective orders.These empty units should be discarded by the personnel in production.Reviewed the batch manufacturing records this product had a normal process and results during process fulfilled the oem specifications.Taking into account that no other complaints have been received regarding this issue, it is considered that this is an isolated and accidental issue.Final conclusion: taking into account that the results of samples received do not fulfill the oem specifications, it is concluded that the complaint is justified.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.This report is being submitted late due to mis-interpretation of 2 year presumption acknowledgement and agreement by fda.Once issue was identified, retrospective review of complaints was completed from time of 2 year presumption implementation to present.All reports identified are being reported.
|